Efficacy and safety of rhBMP/β-TCP in alveolar ridge preservation: a multicenter, randomized, open-label, comparative, investigator-blinded clinical trial
Tóm tắt
The aim of this multicenter, randomized, open-label, comparative, investigator-blinded study was to investigate the efficacy and safety of recombinant human bone morphogenetic protein 2 (rhBMP-2) combined with β-TCP (rhBMP-2/β-TCP) in alveolar ridge preservation. Eighty-four subjects from three centers were enrolled in this clinical trial. After tooth extraction, rhBMP-2/β-TCP (n = 41, test group) or β-TCP (n = 43, control group) were grafted to the extraction socket with an absorbable barrier membrane for alveolar ridge preservation. Using computed tomography images obtained immediately after and 12 weeks after surgery, changes in the alveolar bone height and width were analyzed for each group and compared between the two groups. Both the test and control groups showed a significant decrease in alveolar bone height in the 12 weeks after surgery (both groups, p < 0.0001). However, the test group exhibited a significantly lower decrease in alveolar bone height than the control group (p = 0.0004). Alveolar bone width also showed significantly less resorption in the test group than in the control group for all extraction socket levels (ESL) (p = 0.0152 for 75% ESL; p < 0.0001 for 50% ESL; p < 0.0001 for 25% ESL). There were no statistically significant differences in the incidence of adverse events between the two groups. No severe adverse events occurred in either group. The results of this study suggest that rhBMP-2/β-TCP is a safe graft material that provides a high alveolar bone preservation effect in patients receiving dental extraction.
Clinicaltrials.gov
,
NCT02714829
, Registered 22 March 2016
Tài liệu tham khảo
Schropp L, Wenzel A, Kostopoulos L, Karring T (2003) Bone healing and soft tissue contour changes following single-tooth extraction: a clinical and radiographic 12-month prospective study. Int J Periodontics Restorative Dent 23(4):313–323
Tan WL, Wong TL, Wong MC, Lang NP (2012) A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res 23(Suppl 5):1–21. https://doi.org/10.1111/j.1600-0501.2011.02375.x
Van der Weijden F, Dell'Acqua F, Slot DE (2009) Alveolar bone dimensional changes of post-extraction sockets in humans: a systematic review. J Clin Periodontol 36(12):1048–1058. https://doi.org/10.1111/j.1600-051X.2009.01482.x
Zhao L, Xu T, Hu W, Chung KH (2018) Preservation and augmentation of molar extraction sites affected by severe bone defect due to advanced periodontitis: a prospective clinical trial. Clin Implant Dent Relat Res 20(3):333–344. https://doi.org/10.1111/cid.12585
Lee JH, Kim DH, Jeong SN (2020) Comparative assessment of anterior maxillary alveolar ridge preservation with and without adjunctive use of enamel matrix derivative: a randomized clinical trial. Clin Oral Implants Res 31(1):1–9. https://doi.org/10.1111/clr.13530
Brkovic BM, Prasad HS, Rohrer MD, Konandreas G, Agrogiannis G, Antunovic D, Sandor GK (2012) Beta-tricalcium phosphate/type I collagen cones with or without a barrier membrane in human extraction socket healing: clinical, histologic, histomorphometric, and immunohistochemical evaluation. Clin Oral Investig 16(2):581–590. https://doi.org/10.1007/s00784-011-0531-1
Gholami GA, Najafi B, Mashhadiabbas F, Goetz W, Najafi S (2012) Clinical, histologic and histomorphometric evaluation of socket preservation using a synthetic nanocrystalline hydroxyapatite in comparison with a bovine xenograft: a randomized clinical trial. Clin Oral Implants Res 23(10):1198–1204. https://doi.org/10.1111/j.1600-0501.2011.02288.x
Wood RA, Mealey BL (2012) Histologic comparison of healing after tooth extraction with ridge preservation using mineralized versus demineralized freeze-dried bone allograft. J Periodontol 83(3):329–336. https://doi.org/10.1902/jop.2011.110270
Kim YK, Yun PY, Lee HJ, Ahn JY, Kim SG (2011) Ridge preservation of the molar extraction socket using collagen sponge and xenogeneic bone grafts. Implant Dent 20(4):267–272. https://doi.org/10.1097/ID.0b013e3182166afc
Jo DW, Cho YD, Seol YJ, Lee YM, Lee HJ, Kim YK (2019) A randomized controlled clinical trial evaluating efficacy and adverse events of different types of recombinant human bone morphogenetic protein-2 delivery systems for alveolar ridge preservation. Clin Oral Implants Res 30(5):396–409. https://doi.org/10.1111/clr.13423
Avila-Ortiz G, Chambrone L, Vignoletti F (2019) Effect of alveolar ridge preservation interventions following tooth extraction: a systematic review and meta-analysis. J Clin Periodontol 46(Suppl 21):195–223. https://doi.org/10.1111/jcpe.13057
Ogose A, Hotta T, Hatano H, Kawashima H, Tokunaga K, Endo N, Umezu H (2002) Histological examination of beta-tricalcium phosphate graft in human femur. J Biomed Mater Res 63(5):601–604. https://doi.org/10.1002/jbm.10380
Tamura K, Sato S, Kishida M, Asano S, Murai M, Ito K (2007) The use of porous beta-tricalcium phosphate blocks with platelet-rich plasma as an onlay bone graft biomaterial. J Periodontol 78(2):315–321. https://doi.org/10.1902/jop.2007.060228
Fukuba S, Akizuki T, Matsuura T, Okada M, Nohara K, Hoshi S, Shujaa Addin A, Iwata T, Izumi Y (2021) Effects of combined use of recombinant human fibroblast growth factor-2 and beta-tricalcium phosphate on ridge preservation in dehiscence bone defects after tooth extraction: a split-mouth study in dogs. J Periodontal Res 56(2):298–305. https://doi.org/10.1111/jre.12818
Urist MR (1965) Bone: formation by autoinduction. Science 150(3698):893–899. https://doi.org/10.1126/science.150.3698.893
Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11(6):471–491. https://doi.org/10.1016/j.spinee.2011.04.023
Jung RE, Glauser R, Scharer P, Hammerle CH, Sailer HF, Weber FE (2003) Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14(5):556–568. https://doi.org/10.1034/j.1600-0501.2003.00921.x
Kim HJ, Chung JH, Shin SY, Shin SI, Kye SB, Kim NK, Kwon TG, Paeng JY, Kim JW, Oh OH, Kook MS, Yang HJ, Hwang SJ (2015) Efficacy of rhBMP-2/hydroxyapatite on sinus floor augmentation: a multicenter, randomized controlled clinical trial. J Dent Res 94(9 Suppl):158S–165S. https://doi.org/10.1177/0022034515594573
Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, Boyne PJ (2009) Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67(9):1947–1960. https://doi.org/10.1016/j.joms.2009.04.085
Huh JB, Lee HJ, Jang JW, Kim MJ, Yun PY, Kim SH, Choi KH, Kim YK, Cho KS, Shin SW (2011) Randomized clinical trial on the efficacy of Escherichia coli-derived rhBMP-2 with beta-TCP/HA in extraction socket. J Adv Prosthodont 3(3):161–165. https://doi.org/10.4047/jap.2011.3.3.161
Kim YJ, Lee JY, Kim JE, Park JC, Shin SW, Cho KS (2014) Ridge preservation using demineralized bone matrix gel with recombinant human bone morphogenetic protein-2 after tooth extraction: a randomized controlled clinical trial. J Oral Maxillofac Surg 72(7):1281–1290. https://doi.org/10.1016/j.joms.2014.01.022
Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M (2005) Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 76(4):605–613. https://doi.org/10.1902/jop.2005.76.4.605
Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L (1986) A modified gingival index for use in clinical trials. Clin Prev Dent 8(1):3–6
Horowitz RA, Mazor Z, Miller RJ, Krauser J, Prasad HS, Rohrer MD (2009) Clinical evaluation alveolar ridge preservation with a beta-tricalcium phosphate socket graft. Compend Contin Educ Dent 30(9):588–590 592, 594 passim; quiz 604, 606
Leventis MD, Fairbairn P, Kakar A, Leventis AD, Margaritis V, Luckerath W, Horowitz RA, Rao BH, Lindner A, Nagursky H (2016) Minimally invasive alveolar ridge preservation utilizing an in situ hardening beta-tricalcium phosphate bone substitute: a multicenter case series. Int J Dent 2016:5406736–5406712. https://doi.org/10.1155/2016/5406736
Takahashi Y, Marukawa E, Omura K (2013) Application of a new material (beta-TCP/collagen composites) in extraction socket preservation: an experimental study in dogs. Int J Oral Maxillofac Implants 28(2):444–452. https://doi.org/10.11607/jomi.2794
Saito H, Couso-Queiruga E, Shiau HJ, Stuhr S, Prasad H, Allareddy TV, Reynolds MA, Avila-Ortiz G (2021) Evaluation of poly lactic-co-glycolic acid-coated beta-tricalcium phosphate for alveolar ridge preservation: a multicenter randomized controlled trial. J Periodontol 92(4):524–535. https://doi.org/10.1002/JPER.20-0360
Chang AR, Cho TH, Hwang SJ (2017) Receptor activator of nuclear factor kappa-B ligand-induced local osteoporotic canine mandible model for the evaluation of peri-implant bone regeneration. Tissue Eng Part C Methods 23(11):781–794. https://doi.org/10.1089/ten.TEC.2017.0196
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23(12):2709–2728. https://doi.org/10.1007/s11095-006-9104-4
Lee JH, Baek HR, Lee KM, Lee HK, Im SB, Kim YS, Lee JH, Chang BS, Lee CK (2014) The effect of poloxamer 407-based hydrogel on the osteoinductivity of demineralized bone matrix. Clin Orthop Surg 6(4):455–461. https://doi.org/10.4055/cios.2014.6.4.455